These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 21082267)
1. Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma. Hensen EF; Bayley JP Fam Cancer; 2011 Jun; 10(2):355-63. PubMed ID: 21082267 [TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851 [TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients. Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167 [TBL] [Abstract][Full Text] [Related]
5. SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Papathomas TG; Oudijk L; Persu A; Gill AJ; van Nederveen F; Tischler AS; Tissier F; Volante M; Matias-Guiu X; Smid M; Favier J; Rapizzi E; Libe R; Currás-Freixes M; Aydin S; Huynh T; Lichtenauer U; van Berkel A; Canu L; Domingues R; Clifton-Bligh RJ; Bialas M; Vikkula M; Baretton G; Papotti M; Nesi G; Badoual C; Pacak K; Eisenhofer G; Timmers HJ; Beuschlein F; Bertherat J; Mannelli M; Robledo M; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger RR Mod Pathol; 2015 Jun; 28(6):807-21. PubMed ID: 25720320 [TBL] [Abstract][Full Text] [Related]
11. Models of parent-of-origin tumorigenesis in hereditary paraganglioma. Hoekstra AS; Devilee P; Bayley JP Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997 [TBL] [Abstract][Full Text] [Related]
12. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations. Baysal BE; Maher ER Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606 [TBL] [Abstract][Full Text] [Related]
13. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas. Gupta S; Erickson LA Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159 [TBL] [Abstract][Full Text] [Related]
14. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. Bayley JP; Devilee P; Taschner PE BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866 [TBL] [Abstract][Full Text] [Related]
17. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. Pasini B; Stratakis CA J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823 [TBL] [Abstract][Full Text] [Related]
18. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients. Bayley JP; Grimbergen AE; van Bunderen PA; van der Wielen M; Kunst HP; Lenders JW; Jansen JC; Dullaart RP; Devilee P; Corssmit EP; Vriends AH; Losekoot M; Weiss MM BMC Med Genet; 2009 Apr; 10():34. PubMed ID: 19368708 [TBL] [Abstract][Full Text] [Related]
19. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot? Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955 [TBL] [Abstract][Full Text] [Related]
20. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Astuti D; Latif F; Dallol A; Dahia PL; Douglas F; George E; Sköldberg F; Husebye ES; Eng C; Maher ER Am J Hum Genet; 2001 Jul; 69(1):49-54. PubMed ID: 11404820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]